| Disrupting tumour blood vessels GM Tozer, C Kanthou, BC Baguley Nature Reviews Cancer 5, 423-435, 2005 | 1138 | 2005 |
| Signaling pathways in melanogenesis SAN D’Mello, GJ Finlay, BC Baguley, ME Askarian-Amiri International journal of molecular sciences 17 (7), 1144, 2016 | 993 | 2016 |
| Quenching of DNA-ethidium fluorescence by amsacrine and other antitumor agents: a possible electron-transfer effect BC Baguley, M Le Bret Biochemistry 23 (5), 937-943, 1984 | 662 | 1984 |
| Multiple drug resistance mechanisms in cancer BC Baguley Molecular biotechnology 46, 308-316, 2010 | 643 | 2010 |
| Potential antitumor agents. 59. Structure-activity relationships for 2-phenylbenzimidazole-4-carboxamides, a new class of ‘minimal’ DNA-intercalating agents which may not act … WA Denny, GW Rewcastle, BC Baguley Journal of Medicinal Chemistry 33, 814-819, 1990 | 438 | 1990 |
| Epigenetic regulation in human melanoma: past and future D Sarkar, EY Leung, BC Baguley, GJ Finlay, ME Askarian-Amiri Epigenetics 10 (2), 103-121, 2015 | 298 | 2015 |
| Potential antitumor agents. 50. In vivo solid tumor activity of derivatives of N[2-(dimethylamino)ethyl]-acridine 4-carboxamide GJ Atwell, GW Rewcastle, BC Baguley, D WA vivo 30, 664-669, 1987 | 275 | 1987 |
| Potential antitumor agents. 61. Structure-activity relationships for in vivo colon 38 activity among disubstituted 9-oxo-9H-xanthene-4-acetic acids GW Rewcastle, GJ Atwell, L Zhuang, BC Baguley, WA Denny Journal of medicinal chemistry 34 (1), 217-222, 1991 | 266 | 1991 |
| Potential antitumor agents. Part 34. Quantitative relationships between DNA binding and molecular structure for 9-anilinoacridines substituted in the anilino ring BC Baguley, WA Denny, GJ Atwell, BF Cain Journal of Medicinal Chemistry 24, 170-177, 1981 | 266 | 1981 |
| A semiautomated microculture method for investigating growth inhibitory effects of cytotoxic compounds on exponentially growing carcinoma cells GJ Finlay, BC Baguley, WR Wilson Anal Biochem 139, 272-277, 1984 | 261 | 1984 |
| Role of lipophilicity in determining cellular uptake and antitumour activity of gold phosphine complexes MJ McKeage, SJ Berners-Price, P Galettis, RJ Bowen, W Brouwer, L Ding, ... Cancer chemotherapy and pharmacology 46, 343-350, 2000 | 259 | 2000 |
| Relationships between hydrophobicity, reactivity, accumulation and peripheral nerve toxicity of a series of platinum drugs D Screnci, MJ McKeage, P Galettis, TW Hambley, BD Palmer, BC Baguley British journal of cancer 82 (4), 966-972, 2000 | 247 | 2000 |
| DNA-directed alkylating agents. 6. Synthesis and antitumor activity of DNA minor groove-targeted aniline mustard analogs of pibenzimol (Hoechst 33258) GL Gravatt, BC Baguley, WR Wilson, WA Denny Journal of medicinal chemistry 37 (25), 4338-4345, 1994 | 243 | 1994 |
| Potential antitumor agents. 28. Deoxyribonucleic acid polyintercalating agents BF Cain, BC Baguley, WA Denny Journal of Medicinal Chemistry 21, 658-668, 1978 | 241 | 1978 |
| Antivascular therapy of cancer: DMXAA BC Baguley The lancet oncology 4 (3), 141-148, 2003 | 237 | 2003 |
| In vitro antitumour and hepatotoxicity profiles of Au(I) and Ag(I) bidentate pyridyl phosphine complexes and relationships to uptake. JJ Liu, P Galettis, A Farr, L Maharaj, H Samarasinha, AC McGechan, ... Journal of Inorganic Biochemistry 102, 303-310, 2008 | 234 | 2008 |
| Inhibition of growth of colon 38 adenocarcinoma by vinblastine and colchicine: evidence for a vascular mechanism BC Baguley, KM Holdaway, LL Thomsen, L Zhuang, LJ Zwi European Journal of Cancer and Clinical Oncology 27 (4), 482-487, 1991 | 233 | 1991 |
| Differences in the carcinogenic evaluation of glyphosate between the International Agency for Research on Cancer (IARC) and the European Food Safety Authority (EFSA) CJ Portier, BK Armstrong, BC Baguley, X Baur, I Belyaev, R Bellé, ... J Epidemiol Community Health 70 (8), 741-745, 2016 | 228 | 2016 |
| The interaction of ethidium with synthetic double-stranded polynucleotides at low ionic strength BC Baguley, EM Falkenhaug Nucleic Acids Research 5 (1), 161-171, 1978 | 225 | 1978 |
| Mutation-specific RAS oncogenicity explains NRAS codon 61 selection in melanoma CE Burd, W Liu, MV Huynh, MA Waqas, JE Gillahan, KS Clark, K Fu, ... Cancer discovery 4 (12), 1418-1429, 2014 | 223 | 2014 |
William A DennyDistinguished Professor, The University of Auckland在 auckland.ac.nz 的电子邮件经过验证
